SLC38A5 and neoplasm: Having identified mTORC1 signaling pathway inactivation as a mechanism for tumor attenuation in response to SLC38A5 knockout, we were curious to identify additional pathways or targets that could function either independently or in conjunction with mTORC1 pathway, to reduce tumor growth in PDAC.